Anti-Aging Stack

Aging isn't one clock. Geroscience counts at least a dozen clocks. They tick at different speeds. Different interventions can slow each one.The Anti-Aging Stack picks three that rarely get addressed together. Epithalon is a synthetic tetrapeptide. It has been studied for reactivating telomerase — the enzyme that keeps chromosome ends intact — in normal cells that have silenced it [PMID: 12398480]. GHK-Cu is a copper-binding tripeptide. Its levels in blood drop as collagen fades [PMID: 26236730]. NAD+ is a coenzyme. It fuels sirtuins, PARP repair enzymes, and mitochondria [PMID: 24786309, 31065944].The selection is deliberate non-overlap. Chromosomal erosion, tissue decay, and energy decline are separate clocks. Each is driven by its own mechanism.If you noticed grayer hair, slower recovery, and fading stamina in one year, you watched three clocks run at once. That is why one compound feels incomplete.Ahead you find what each compound's research shows, how the layers stack, and where evidence thins out. Most findings are preclinical. Only NAD+ precursors have early human trials. No regulator has approved this combination. That context frames everything below.

Epithalon takes the chromosomal layer. The tetrapeptide may reactivate hTERT — the gene for telomerase — in normal cells [PMID: 12398480]. Telomerase keeps chromosome ends intact. Animal studies report longer lifespan with chronic use [PMID: 15865243].Research also links the peptide to melatonin. Melatonin is a hormone that helps set the sleep cycle. Pineal cells grow less responsive with age, so melatonin drops. Epithalon may restore that response [PMID: 10709557].GHK-Cu takes the structural layer. Its own level tracks aging. In young adults, blood levels sit near 200 ng/mL. In older adults, they fall near zero [PMID: 29986520].Studies suggest the peptide raises collagen and elastin in fibroblasts. These are the proteins that keep skin firm and tissue strong [PMID: 26236730]. It also raises antioxidant genes like superoxide dismutase. That gene fights stress rather than passively soaking up free radicals [PMID: 26236730]. The peptide may also raise blood vessel growth, which helps tissue repair [PMID: 29986520].NAD+ takes the energy layer. The coenzyme fuels sirtuins. Sirtuins control mitochondria, metabolism, and stress response [PMID: 24786309]. It also feeds PARP enzymes. PARP repairs DNA strand breaks [PMID: 31065944].NAD+ levels drop with age. CD38, an enzyme in older tissues, breaks NAD+ down faster [PMID: 26785480]. Since sirtuins and PARPs share the same NAD+ pool, this drain hits both systems [PMID: 26785480].Three compounds cover three separate parts of aging. The synergy case rests on coherence, not chemistry. It remains untested — no study has combined all three. The protocol notes ahead show how differently each clock must be read.

Three compounds, three ways to take them. Reconciling them is the real challenge of this stack.Epithalon is studied mainly as a subcutaneous shot at 5–10 mg per day. Courses last about 10 days and repeat every few months [PMID: 15865243]. The idea is pulsatile dosing — a short telomerase burst may trigger longer changes. The peptide leaves blood in minutes, yet effects seem to last. Intranasal use has been tried but lacks standard dosing.GHK-Cu research uses two routes. Topical forms at 0.1–1% target skin endpoints like collagen and wound healing. Shots under the skin target deeper tissue [PMID: 26236730]. The peptide leaves blood fast, so repeat dosing sustains levels. The formula matters too — pH, solvent, and penetration enhancers change how much the body absorbs.NAD+ is studied almost only through oral precursors. Trials use nicotinamide riboside at 100–2000 mg/day or nicotinamide mononucleotide at 250–900 mg/day. Both raise blood NAD+ in a dose-dependent way [PMID: 29184669, 32320006, 36482258]. Human trials agree across separate studies [PMID: 36482258]. Direct IV or shot forms appear in research but lack trial support.Mixing all three means mixing pulsatile shot courses, regular topical or injectable doses, and daily pills. No combined protocol exists yet. Every figure here is a reference point, not a recipe. That frames the questions ahead.